Trump to announce pharma tariffs soon

U.S. President Donald Trump said on Friday that he would soon announce tariffs targeting the pharmaceutical industry but did not provide details on timing or rates.

Speaking to reporters aboard Air Force One, Trump also stated that he was open to negotiating deals with countries seeking to avoid U.S. tariffs, but such agreements would have to come after his administration announces reciprocal tariffs on April 2.

Countries including Britain have approached the U.S. to discuss potential deals, Trump said.

“They want to make deals. It’s possible if we can get something for the deal,” he noted. However, when asked if these deals could happen before April 2, he ruled it out, saying, “No, probably later. It’s a process.”

Earlier, President Trump announced a 25% tariff on auto imports, claiming it would boost domestic manufacturing. The White House expects the move to generate $100 billion annually, but it could strain automakers reliant on global supply chains.

The tariffs, set to take effect in April, may raise costs and lower sales, though Trump insists they will lead to more U.S. factories.

Declaring the decision “permanent,” he also warned the EU and Canada of even higher tariffs if they coordinate against the U.S.

Related Posts

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India, a leading healthcare technology company, has expanded its ELUXEO 8000 endoscopy portfolio with the launch of its next-generation therapeutic gastroscopes at Endocon 2026. India is witnessing a growing…

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?